Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise as nonsteroidal treatments for hair loss.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

New compounds may help treat prostate issues without affecting androgen receptors.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

Neonatal neurosteroid levels affect adult brain function and behavior.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Progesterone increases alcohol tolerance and withdrawal anxiety, while DHEAS prevents them.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Allopregnanolone increases KCC2 expression in baby male rats' brains, while finasteride doesn't affect it.

Clascoterone cream could be used for other skin conditions affected by hormones.

Neurosteroids may help prevent seizures and slow epilepsy progression.

Progesterone protects brain cells, but Provera does not.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

Progesterone protects brain cells by converting to allopregnanolone and involving GABAA receptors.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Compound 15a was effective in inhibiting 5α-reductase.

Diet changes hormone levels in pregnant ewes by affecting metabolism, not placental synthesis.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

Early-life neurosteroid changes affect adolescent exploration and adult behavior.

Allopregnanolone may help prevent nicotine withdrawal symptoms.

Lower allopregnanolone levels increase stress-related dopamine release in the brain.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

A new compound effectively inhibits human 5α-reductase 1.

Targeting neurosteroids may help prevent drug relapse.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.